-
METTL3-m6A-LEPR Axis Regulates Trophoblasts in Fetal Growth
2026-07-13
This study uncovers how reduced METTL3-mediated N6-methyladenosine (m6A) modification of the leptin receptor (LEPR) impairs trophoblast function, contributing to fetal growth restriction (FGR). The findings highlight a mechanistic link between RNA methylation and placental pathology, with implications for biomarker development and translational research.
-
MAPK10 Modulates NSCLC Metastasis via KRT16 Phosphorylation-
2026-07-13
This study identifies MAPK10 as a suppressor of non-small cell lung cancer (NSCLC) metastasis through phosphorylation-dependent ubiquitination of keratin 16 (KRT16). The findings provide mechanistic insight into the MAPK10/KRT16/RNF213 axis and highlight its prognostic and therapeutic relevance in NSCLC.
-
PTGER4 Signaling Controls HDAC Activity and SPINK4 in Rectal
2026-07-12
Anbazhagan et al. (2024) delineate how prostaglandin E2-driven PTGER4 signaling modulates class IIa HDAC phosphorylation and SPINK4 mRNA expression in human rectal epithelial cells. These mechanistic insights clarify the molecular links between mesenchymal stromal cell cues and epithelial barrier function, offering new directions for mucosal healing and inflammatory bowel disease research.
-
Protease Inhibitor Cocktail EDTA-Free: Elevating PTM Fidelit
2026-07-10
Explore how the Protease Inhibitor Cocktail EDTA-Free (100X in DMSO) safeguards labile post-translational modifications during protein extraction. Uncover new scientific insights on assay fidelity, succinylation, and phosphorylation analysis, distinct from conventional inhibitor strategies.
-
Biomimetic Chromatography for Pulmonary Drug Permeability As
2026-07-09
This study delivers a direct comparison of immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) for predicting drug partitioning and permeability across the respiratory mucosa. The findings clarify the relative strengths and technical limitations of these biomimetic approaches, enabling more precise modeling in respiratory drug research.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Pract
2026-07-09
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses protein degradation during extraction and analysis by inhibiting a broad spectrum of proteases without interfering with divalent-cation-dependent workflows. It is best suited for applications such as Western blotting, Co-IP, and kinase assays, but is not recommended where metalloprotease inhibition or DMSO incompatibility is a concern.
-
PBS (Phosphate-Buffered Saline): Technical Parameters and La
2026-07-08
PBS (Phosphate-Buffered Saline) addresses the need for a sterile, isotonic buffer solution with physiological pH stability in laboratory research. It is designed for applications such as cell washing and reagent dilution where controlled osmolarity and non-toxicity are critical. This product is not suitable for diagnostic, clinical, or in vivo use.
-
Gallein (SKU B7271): Optimizing GPCR Signaling and Viability
2026-07-08
Gallein (SKU B7271) is a rigorously validated G protein βγ subunit inhibitor that empowers biomedical researchers to dissect GPCR signaling with reproducibility across cancer, immunology, and cardiometabolic models. This article offers scenario-driven guidance on assay optimization, data interpretation, and vendor selection, ensuring robust experimental outcomes and workflow efficiency.
-
LC–MS/MS Mapping of GS-441524 Prodrug Conversion Pathways
2026-07-07
This study introduces a novel GS-441524 prodrug (NGP-1) with structural modifications to improve oral bioavailability and anti-SARS-CoV-2 potential. Using a newly established LC–MS/MS method, the research reveals detailed in vitro and in vivo conversion pathways, informing both pharmacokinetic profiling and future antiviral drug development.
-
NSC 87877: Shp2 Inhibitor Workflows for Neuroinflammation St
2026-07-07
NSC 87877 from APExBIO empowers precise, selective inhibition of Shp2, enabling robust dissection of neuroinflammatory and oncogenic signaling pathways. Its high potency and specificity translate into reproducible workflows for both mechanistic studies and advanced disease modeling.
-
Phenylmethanesulfonyl Fluoride (PMSF): Assay Integrity in Fo
2026-07-06
This article explores how Phenylmethanesulfonyl fluoride (PMSF, SKU A2587) delivers robust, reproducible results in cell viability, proliferation, and cytotoxicity assays. Through scenario-driven Q&A, we address real-world experimental pitfalls and detail why APExBIO’s PMSF is a trusted, evidence-backed choice for serine protease inhibition.
-
Stable Isotope UHPLC-MS/MS for Methylated Purine Quantificat
2026-07-06
This study presents a robust stable isotope-diluted UHPLC-MS/MS method for the accurate quantification of ten methylated purine nucleosides, including 1-methyl Adenosine, in cultured cells. The protocol offers improved sensitivity, recovery, and isomer resolution, facilitating advanced RNA modification research and biomarker discovery in disease contexts.
-
LY294002: Applied PI3K/Akt/mTOR Pathway Inhibition Workflows
2026-07-05
LY294002 empowers precise modulation of PI3K/Akt/mTOR and related pathways, enabling researchers to dissect apoptosis, autophagy, and fibrosis mechanisms in both cancer and fibrotic disease models. This guide translates recent mechanistic findings into actionable protocols, troubleshooting strategies, and advanced applications for reliable, reproducible results.
-
Okadaic acid: Practical Guide for PP1/PP2A Inhibition Studie
2026-07-04
Okadaic acid enables precise inhibition of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) in biochemical and cell-based workflows, facilitating the investigation of phosphorylation-dependent signaling, apoptosis induction, and related processes. It is best applied in controlled research settings where off-target phosphatase inhibition and solvent effects are monitored. Use outside validated assays or in workflows sensitive to broad phosphatase disruption is not recommended.
-
BMAL1 Phase Separation Regulates Circadian Transcriptional H
2026-07-03
Gao et al. reveal that BMAL1, a core circadian clock factor, forms dynamic nuclear condensates through phase separation, directly linking its intrinsically disordered region and phosphorylation state to the timing and robustness of circadian transcription. These findings clarify a longstanding gap in how transcriptional feedback loops are temporally coordinated, with significant implications for studying protein phosphorylation in clock regulation.